Pictet Group’s wholly owned alternative investment business Pictet Alternative Advisors (PAA) has added to its thematic private equity franchise with the launch of a strategy focused on biotech and healthcare investments.
The new strategy aims to invest in biotech and healthcare-focused venture capital, growth and private equity funds globally and will make a "substantial" allocation to co-investments within five key segments...
To continue reading this article...
Join Investment week
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
